Latest News about ARDS
Recent news which mentions ARDS
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 24, 2022
From Benzinga
From Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
August 22, 2022
From Benzinga
Why MSP Recovery Is Trading Higher By Over 21%, Here Are 61 Stocks Moving In Monday's Mid-Day Session
August 22, 2022
From Benzinga
Aridis Pharmaceuticals Return On Capital Employed Overview
August 17, 2022
Tickers
ARDS
From Benzinga
From Benzinga
Aridis' Inhaled Pan-Coronavirus Antibody Cocktail Shows Encouraging Preclinical Action
August 10, 2022
Tickers
ARDS
From Benzinga
This Communication Services Stock Jumped 149%; Here Are 90 Biggest Movers From Friday
August 01, 2022
From Benzinga
From Benzinga
From Benzinga
Why Shares of Solar Companies Are Trading Higher? 64 Stocks Moving In Thursday's Mid-Day Session
July 28, 2022
From Benzinga
From InvestorPlace
From Benzinga
From Benzinga
91 Biggest Movers From Friday
June 13, 2022
From Benzinga
From Benzinga
76 Biggest Movers From Yesterday
May 19, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
April 04, 2022
From Benzinga
From InvestorPlace
From Benzinga
30 Stocks Moving in Tuesday's Pre-Market Session
February 22, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
February 18, 2022
From Benzinga
Tetra Bio-Pharma Gets CA$4.5M From Québec's Government To Develop Medicine For ARDS
February 16, 2022
From Benzinga
From InvestorPlace
5 Short Squeeze Candidate To Watch: Aridis Pharmaceuticals Tops List, EVgo, Indonesia Energy Corp And More
February 14, 2022
From Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
February 04, 2022
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.